Memorandum of Understanding and Agreement: Clinical Trials and Other Human-Use Protocols Involving Recombinant DNA and Biohazardous AgentsMemorandum of Understanding • August 27th, 2022
Contract Type FiledAugust 27th, 2022Deliberate transfer of rDNA, DNA, or RNA derived from recombinant DNA, into human research participants (human gene transfer) and/or application of biohazardous agents to human subjects requires completion/submission of this form to the Biosafety Officer.